erlotinib hydrochloride

erlotinib hydrochloride

(ĕr′lō′tə-nĭb)
n.
A tyrosine kinase inhibitor used in the treatment of certain forms of non-small cell lung cancer and pancreatic cancer.
Mentioned in ?
References in periodicals archive ?
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
has entered into a settlement agreement with OSI, Pfizer and Genentech that will resolve patent litigation related to Erlotinib Hydrochloride Tablets, 25 mg, 100 mg and 150 mg.
District Court in Delaware in connection with the ANDA filing for Erlotinib Hydrochloride (HCl) Tablets, 25 mg, 100 mg and 150 mg.